RNXT
Price
$1.23
Change
+$0.03 (+2.50%)
Updated
Aug 7, 10:39 AM (EDT)
Capitalization
43.89M
7 days until earnings call
SLNCF
Price
$1.69
Change
+$0.08 (+5.00%)
Updated
Aug 4 closing price
Capitalization
238.75M
Interact to see
Advertisement

RNXT vs SLNCF

Header iconRNXT vs SLNCF Comparison
Open Charts RNXT vs SLNCFBanner chart's image
RenovoRx
Price$1.23
Change+$0.03 (+2.50%)
Volume$953
Capitalization43.89M
Silence Therapeutics
Price$1.69
Change+$0.08 (+5.00%)
Volume$300
Capitalization238.75M
RNXT vs SLNCF Comparison Chart in %
Loading...
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNXT vs. SLNCF commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNXT is a Hold and SLNCF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (RNXT: $1.20 vs. SLNCF: $1.68)
Brand notoriety: RNXT and SLNCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNXT: 66% vs. SLNCF: 66%
Market capitalization -- RNXT: $43.89M vs. SLNCF: $238.75M
RNXT [@Biotechnology] is valued at $43.89M. SLNCF’s [@Biotechnology] market capitalization is $238.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNXT’s FA Score shows that 0 FA rating(s) are green whileSLNCF’s FA Score has 1 green FA rating(s).

  • RNXT’s FA Score: 0 green, 5 red.
  • SLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, SLNCF is a better buy in the long-term than RNXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNXT’s TA Score shows that 2 TA indicator(s) are bullish while SLNCF’s TA Score has 4 bullish TA indicator(s).

  • RNXT’s TA Score: 2 bullish, 5 bearish.
  • SLNCF’s TA Score: 4 bullish, 0 bearish.
According to our system of comparison, SLNCF is a better buy in the short-term than RNXT.

Price Growth

RNXT (@Biotechnology) experienced а 0.00% price change this week, while SLNCF (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

RNXT is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNCF($239M) has a higher market cap than RNXT($43.9M). RNXT YTD gains are higher at: -6.977 vs. SLNCF (-35.810). RNXT has higher annual earnings (EBITDA): -11.6M vs. SLNCF (-71.65M). SLNCF has more cash in the bank: 137M vs. RNXT (14.6M). SLNCF has less debt than RNXT: SLNCF (60K) vs RNXT (283K). SLNCF has higher revenues than RNXT: SLNCF (27.7M) vs RNXT (240K).
RNXTSLNCFRNXT / SLNCF
Capitalization43.9M239M18%
EBITDA-11.6M-71.65M16%
Gain YTD-6.977-35.81019%
P/E RatioN/AN/A-
Revenue240K27.7M1%
Total Cash14.6M137M11%
Total Debt283K60K472%
FUNDAMENTALS RATINGS
SLNCF: Fundamental Ratings
SLNCF
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNXTSLNCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
56%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
54%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
51%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 29 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 3 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRRVX9.39N/A
N/A
Columbia Real Estate Equity Inst2
MSHOX14.56N/A
N/A
Morgan Stanley Inst Permanence C
GONCX30.38N/A
N/A
JHancock International Growth C
NMAVX12.25N/A
N/A
Nuance Mid Cap Value Investor
PGHAX60.48-0.90
-1.47%
Putnam Global Health Care R6

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and TARA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and TARA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-1.64%
TARA - RNXT
27%
Poorly correlated
-1.27%
IMRX - RNXT
26%
Poorly correlated
-1.40%
VTVT - RNXT
24%
Poorly correlated
N/A
SLNCF - RNXT
24%
Poorly correlated
N/A
CRVS - RNXT
24%
Poorly correlated
-2.80%
More

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
ENVB - SLNCF
29%
Poorly correlated
-4.96%
RNXT - SLNCF
24%
Poorly correlated
-1.64%
QLGN - SLNCF
21%
Poorly correlated
-7.37%
SOLTF - SLNCF
9%
Poorly correlated
N/A
PVCT - SLNCF
8%
Poorly correlated
-8.32%
More